Proxima, a biotech startup using artificial intelligence to design drugs that control protein interactions, raised $80 ...

A recently identified bacterial protein, named BeeR, is contributing to the design of novel anticancer drug delivery systems. Researchers from King’s College London (UK) and the University of ...

Illustration showing how integrating protein three-dimensional structures with artificial intelligence algorithms can predict synergistic or antagonistic effects of drug combinations, guiding safer ...

Some proteins shift their shape when exposed to different temperatures, revealing previously unknown binding sites for medications. The findings could revolutionize wide swathes of biology by ...

The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain. While symptoms can now be better managed with lifelong treatment, there is ...

The question has been lingering for years in medical science circles. Since 2020, when the artificial intelligence (AI) model AlphaFold made it possible to predict protein structures, would the ...

Researchers identify a shared RNA-protein interaction that could lead to broad-spectrum antiviral treatments for enteroviruses ...

Researchers from David Baker's lab (University of Washington) have designed this antibody from scratch to neutralize a deadly toxin from C. difficile. [Ian Haydon] “Life could not exist without ...

An international research team reveals new molecular mechanisms associated with pathogenic mutations in the protein ...

The New York-based company, previously known as VantAI and incubated at Roivant before a spinoff, is working in a ...